- Home
- IMTX vs AOD Comparison
IMTX vs AOD Comparison
Compare IMTX & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- AOD
- Stock Information
- Founded
- IMTX N/A
- AOD 2006
- Country
- IMTX Germany
- AOD United States
- Employees
- IMTX N/A
- AOD N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- AOD Investment Managers
- Sector
- IMTX Health Care
- AOD Finance
- Exchange
- IMTX Nasdaq
- AOD Nasdaq
- Market Cap
- IMTX 954.2M
- AOD 918.3M
- IPO Year
- IMTX N/A
- AOD N/A
- Fundamental
- Price
- IMTX $7.08
- AOD $8.62
- Analyst Decision
- IMTX Strong Buy
- AOD
- Analyst Count
- IMTX 4
- AOD 0
- Target Price
- IMTX $16.67
- AOD N/A
- AVG Volume (30 Days)
- IMTX 522.7K
- AOD 301.9K
- Earning Date
- IMTX 11-18-2024
- AOD 01-01-0001
- Dividend Yield
- IMTX N/A
- AOD 8.43%
- EPS Growth
- IMTX N/A
- AOD N/A
- EPS
- IMTX N/A
- AOD N/A
- Revenue
- IMTX $128,824,447.00
- AOD N/A
- Revenue This Year
- IMTX $90.79
- AOD N/A
- Revenue Next Year
- IMTX N/A
- AOD N/A
- P/E Ratio
- IMTX N/A
- AOD N/A
- Revenue Growth
- IMTX 52.53
- AOD N/A
- 52 Week Low
- IMTX $6.99
- AOD $7.02
- 52 Week High
- IMTX $13.77
- AOD $8.45
- Technical
- Relative Strength Index (RSI)
- IMTX 27.93
- AOD 37.66
- Support Level
- IMTX $6.99
- AOD $8.57
- Resistance Level
- IMTX $7.40
- AOD $8.67
- Average True Range (ATR)
- IMTX 0.30
- AOD 0.06
- MACD
- IMTX -0.00
- AOD -0.01
- Stochastic Oscillator
- IMTX 10.46
- AOD 5.77
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. It predominantly invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, Industrials among other sectors.